TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 8nMAssay Description:Inhibitory concentration against Human Serine Protease Urokinase Plasminogen ActivatorMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 8nMAssay Description:Inhibition of urokinase-type plasminogen activatorMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 8nM ΔG°: -45.7kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 9nM ΔG°: -45.5kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 11nM ΔG°: -45.0kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 11nMAssay Description:Inhibition of urokinase-type plasminogen activatorMore data for this Ligand-Target Pair
Affinity DataKi: 14nMAssay Description:Binding affinity against human coagulation factor XMore data for this Ligand-Target Pair
Affinity DataKi: 19nMAssay Description:Inhibition of Human Serine Protease tissue type Plasminogen Activator (t-PA).More data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 20nM ΔG°: -43.5kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 25nMAssay Description:ComInhibition of Human Serine Protease Urokinase Plasminogen Activator (u-PA).More data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 25nM ΔG°: -43.0kJ/molepH: 8.2 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
Affinity DataKi: 26nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 32nMAssay Description:Inhibition of urokinase-type plasminogen activatorMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 32nMAssay Description:Inhibition of urokinase-type plasminogen activatorMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 35nMAssay Description:Inhibitory concentration against Human Serine Protease Urokinase Plasminogen ActivatorMore data for this Ligand-Target Pair
Affinity DataKi: 35nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
Affinity DataKi: 35nMAssay Description:Inhibition of tissue-type plasminogen activatorMore data for this Ligand-Target Pair
Affinity DataKi: 35nMAssay Description:Inihibtion of Human Serine Protease tissue type Plasminogen ActivatorMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 38nMAssay Description:Inhibitory concentration against Human Serine Protease Urokinase Plasminogen ActivatorMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 43nMAssay Description:Inhibitory concentration against Human Serine Protease Urokinase Plasminogen ActivatorMore data for this Ligand-Target Pair
Affinity DataKi: 43nMAssay Description:Binding affinity against human coagulation factor XMore data for this Ligand-Target Pair
Affinity DataKi: 52nMAssay Description:Binding affinity against human coagulation factor XMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 55nMAssay Description:ComInhibition of Human Serine Protease Urokinase Plasminogen Activator (u-PA).More data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 55nMAssay Description:Inhibitory concentration against Human Serine Protease Urokinase Plasminogen ActivatorMore data for this Ligand-Target Pair
Affinity DataKi: 70nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
Affinity DataKi: 75nMAssay Description:Inhibition of Human Serine Protease Trypsin.More data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 77nM ΔG°: -40.2kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
Affinity DataKi: 78nMAssay Description:Binding affinity against human coagulation factor XMore data for this Ligand-Target Pair
Affinity DataKi: 78nMAssay Description:Binding affinity against human coagulation factor XMore data for this Ligand-Target Pair
Affinity DataKi: 78nMAssay Description:Inhibition of Coagulation factor XMore data for this Ligand-Target Pair
Affinity DataKi: 78nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 80nMAssay Description:Inhibition of urokinase-type plasminogen activatorMore data for this Ligand-Target Pair
Affinity DataKi: 89nMAssay Description:Binding affinity against human coagulation factor XMore data for this Ligand-Target Pair
Affinity DataKi: 94nMAssay Description:Inihibtion of Human Serine Protease tissue type Plasminogen ActivatorMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 100nMAssay Description:Inhibitory concentration against Human Serine Protease Urokinase Plasminogen ActivatorMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 100nMAssay Description:Inhibition of urokinase-type plasminogen activatorMore data for this Ligand-Target Pair
Affinity DataKi: 100nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
Affinity DataKi: 100nMAssay Description:Inhibition of Human Serine Protease PlasminMore data for this Ligand-Target Pair
Affinity DataKi: 103nMAssay Description:Displacement of [3H]CCPA from adenosine A1 receptor in Wistar rat cerebral cortex by liquid scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: 110nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
Affinity DataKi: 110nMAssay Description:Inihibtion of Human Serine Protease tissue type Plasminogen ActivatorMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 110nM ΔG°: -39.3kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Axys Pharmaceuticals
Curated by ChEMBL
Axys Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 110nMAssay Description:Inhibition of urokinase-type plasminogen activatorMore data for this Ligand-Target Pair
Affinity DataKi: 110nMAssay Description:Inhibition of Human Serine Protease Thrombin.More data for this Ligand-Target Pair
Affinity DataKi: 120nMAssay Description:Activity against Human Serine Protease ThrombinMore data for this Ligand-Target Pair
Affinity DataKi: 130nMAssay Description:Activity against Human Serine Protease TrypsinMore data for this Ligand-Target Pair
Affinity DataKi: 130nMAssay Description:Activity against Human Serine Protease TrypsinMore data for this Ligand-Target Pair
Affinity DataKi: 130nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
Affinity DataKi: 130nMAssay Description:Activity against Human Serine Protease TrypsinMore data for this Ligand-Target Pair